Log inSign up
Companies › Syndex Bio
Syndex Bio logo

Syndex Bio

Cambridge, UK · ≈26 employees · Research and Development in Biotechnology (except Nanobiotechnology) · syndex.bio

Syndex Bio is a biotechnology platform offering molecular technologies and AI for the diagnosis and treatment of disease.

Artificial Intelligence (AI)BiotechnologyHealth Care

Funding

1
Every round, secondary, debt facility or acquisition involving Syndex Bio that AI Lounge tracks, newest first. Latest: Seed on Feb 23, 2026.
Syndex Bio logo
Syndex BioSeedFeb 23
Arch Venture Partners (lead), +ND Capital, Meltwind Advisory, OMX Ventures · AI
$16M
val. $61M

Timeline · 1

Feb 23, 2026
Round
Seed · $15.5M at $61M · Arch Venture Partners
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in